Zoghbi, Anthony W. http://orcid.org/0000-0002-3441-440X
Lieberman, Jeffrey A.
Girgis, Ragy R. http://orcid.org/0000-0001-5715-8982
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH113861, K23MH121669)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 25 November 2021
Revised: 14 July 2022
Accepted: 21 July 2022
First Online: 5 August 2022
Competing interests
: Within the last 3 years, RRG has received research support from Allergan, consulted for Noble Insights, and received royalties from books published by Wipf and Stock and Routledge/Taylor and Francis. JAL has received support administered through his institution in the form of funding or medication supplies for investigator-initiated research from Lilly, Denovo, Biomarin, Novartis, Taisho, Teva, Alkermes, and Boehringer Ingelheim, and is a member of the advisory board of Intracellular Therapies and Pierre Fabre. He neither accepts nor receives any personal financial remuneration for consulting, advisory board, or research activities. He holds a patent from Repligen and receives royalty payments from <i>SHRINKS: The Untold Story of Psychiatry</i>. AWZ is a paid consultant for AstraZeneca. The project described was supported by K23MH121669 (AWZ) and R01MH113861 (RRG).